Evolutionary rescue: Linking theory for conservation and medicine

Evolutionary Applications

Volumn 7, Issue 10, 2014, Pages 1161-1179

  Alexander, Helen K ^a   Martin, Guillaume ^b   Martin, Oliver Y ^a   Bonhoeffer, Sebastian ^a  

^a ETH ZURICH   (Switzerland)

^b INSTITUT DES SCIENCES DE L EVOLUTION   (France)

Author keywords

Drug resistance; Eco evolutionary feedback; Environmental change; Experimental evolution; Infectious disease; Mathematical model; Spatiotemporal heterogeneity; Standing genetic variation

Indexed keywords

EID: 84914814450     PISSN: 17524563     EISSN: 17524571     Source Type: Journal    
DOI: 10.1111/eva.12221     Document Type: Article

References (138)

1. Agrawal, A. F., and M. C. Whitlock 2010. Environmental duress and epistasis: how does stress affect the strength of selection on new mutations? Trends in Ecology & Evolution 25:450-458.
2. Alexander, H. K., and S. Bonhoeffer 2012. Pre-existence and emergence of drug resistance in a generalized model of intra-host viral dynamics. Epidemics 4:187-202.
3. Alizon, S. 2009. The Price equation framework to study disease within-host evolution. Journal of Evolutionary Biology 22:1123-1132.
4. Anderson, R. M., and R. M. May 1991. Infectious Diseases of Humans: Dynamics and Control. Oxford University Press, Oxford, UK.
5. Anderson, J. P., R. Daifuku, and L. A. Loeb 2004. Viral error catastrophe by mutagenic nucleosides. Annual Review of Microbiology 58:183-205.
6. Ankomah, P., and B. R. Levin 2012. Two-drug antimicrobial chemotherapy: a mathematical model and experiments with Mycobacterium marinum. PLoS Pathogens 8:e1002487.
7. Ankomah, P., and B. R. Levin 2014. Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infections. Proceedings of the National Academy of Sciences of the United States of America 111:8331-8338.
8. Ankomah, P., P. J. Johnson, and B. R. Levin 2013. The pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulations. PLoS Pathogens 9:e1003300.
9. Bakker, J., M. E. C. van Rijswijk, F. J. Weissing, and R. Bijlsma 2010. Consequences of fragmentation for the ability to adapt to novel environments in experimental Drosophila metapopulations. Conservation Genetics 11:435-448.
10. Barrett, R. D. H., and A. P. Hendry 2012. Evolutionary rescue under environmental change? In U. Candolin, and B. B. M. Wong, eds. Behavioural Responses to a Changing World, pp. 216-233. Oxford University Press, Oxford, UK.
11. Barrett, R. D. H., and D. Schluter 2008. Adaptation from standing genetic variation. Trends in Ecology & Evolution 23:38-44.
12. Bell, G. 2013. Evolutionary rescue and the limits of adaptation. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 368:20120080.
13. Bell, G., and S. Collins 2008. Adaptation, extinction and global change. Evolutionary Applications 1:3-16.
14. Bell, G., and A. Gonzalez 2009. Evolutionary rescue can prevent extinction following environmental change. Ecology Letters 12:942-948.
15. Bell, G., and A. Gonzalez 2011. Adaptation and evolutionary rescue in metapopulations experiencing environmental deterioration. Science 332:1327-1330.
16. Berney, M., F. Hammes, F. Bosshard, H. U. Weilenmann, and T. Egli 2007. Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight Kit in combination with flow cytometry. Applied and Environmental Microbiology 73:3283-3290.
17. Bijlsma, R., and V. Loeschke 2012. Genetic erosion impedes adaptive responses to stressful environments. Evolutionary Applications 5:117-129.
18. Bijlsma, R., J. Bundgaard, and A. C. Boerma 2000. Does inbreeding affect the extinction risk of small populations?: predictions from Drosophila. Journal of Evolutionary Biology 13:502-514.
19. Bock, C., and T. Lengauer 2012. Managing drug resistance in cancer: lessons from HIV therapy. Nature Reviews Cancer 12:494-501.
20. Bonhoeffer, S., and M. A. Nowak 1997. Pre-existence and emergence of drug resistance in HIV-1 infection. Proceedings of the Royal Society of London. Series B: Biological Sciences 264:631-637.
21. Bonhoeffer, S., R. M. May, G. M. Shaw, and M. A. Nowak 1997. Virus dynamics and drug therapy. Proceedings of the National Academy of Sciences of the United States of America 94:6971-6976.
22. van den Bosch, F., and C. A. Gilligan 2008. Models of fungicide resistance dynamics. Annual Review of Phytopathology 46:123-147.
23. Boulding, E. G., and T. Hay 2001. Genetic and demographic parameters determining population persistence after a discrete change in the environment. Heredity 86:313-324.
24. Bourne, E. C., G. Bocedi, J. M. J. Travis, R. J. Pakeman, R. W. Brooker, and K. Schiffers 2014. Between migration load and evolutionary rescue: dispersal, adaptation and the response of spatially structured populations to environmental change. Proceedings of the Royal Society of London, Series B: Biological Sciences 281:20132795.
25. Bürger, R., and M. Lynch 1995. Evolution and extinction in a changing environment: a quantitative-genetic analysis. Evolution 49:151-163.
26. Carlson, S. M., C. J. Cunningham, and P. A. H. Westley 2014. Evolutionary rescue in a changing world. Trends in Ecology & Evolution 29:521-530.
27. Chapin, F. S. III, E. S. Zavaleta, V. T. Eviner, R. L. Naylor, P. M. Vitousek, H. L. Reynolds, D. U. Hooper et al. 2000. Consequences of changing biodiversity. Nature 405:234-242.
28. Chevin, L. M., R. Lande, and G. M. Mace 2010. Adaptation, plasticity, and extinction in a changing environment: towards a predictive theory. PLoS Biology 8:e1000357.
29. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
30. Coldman, A. J., and J. H. Goldie 1983. A model for the resistance of tumor cells to cancer chemotherapeutic agents. Mathematical Biosciences 65:291-307.
31. Coldman, A. J., and J. H. Goldie 1986. A stochastic model for the origin and treatment of tumors containing drug-resistant cells. Bulletin of Mathematical Biology 48:279-292.
32. Colijn, C., T. Cohen, A. Ganesh, and M. Murray 2011. Spontaneous emergence of multiple drug resistance in tuberculosis before and during therapy. PLoS ONE 6:e18327.
33. Collins, S., and J. de Meaux 2009. Adaptation to different rates of environmental change in Chlamydomonas. Evolution 63:2952-2965.
34. Csardi, G., and T. Nepusz 2006. The igraph software package for complex network research. InterJournal Complex Systems 1695.
35. David, H. L. 1970. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Applied Microbiology 20:810-814.
36. Day, T. 2005. Modelling the ecological context of evolutionary change: déjà vu or something new? In K. Cuddington, and B. E. Beisner, eds. Ecological Paradigms Lost: Routes of Theory Change, pp. 273-309. Elsevier Academic Press, Burlington, MA.
37. Day, T., and S. Gandon 2006. Insights from Price's equation into evolutionary epidemiology. In Z. Feng, U. Dieckmann, and S. Levin, eds. Disease Evolution: Models, Concepts, and Data Analyses, pp. 23-43. American Mathematical Society, Providence, RI.
38. Day, T., and S. Gandon 2007. Applying population-genetic models in theoretical evolutionary epidemiology. Ecology Letters 10:876-888.
39. Day, T., and S. Gandon 2012. The evolutionary epidemiology of multilocus drug resistance. Evolution 66:1582-1597.
40. Day, T., and S. R. Proulx 2004. A general theory for the evolutionary dynamics of virulence. The American Naturalist 163:E40-E63.
41. Ferrière, R., and S. Legendre 2013. Eco-evolutionary feedbacks, adaptive dynamics and evolutionary rescue theory. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 368:20120081.
42. Ferrière, R., U. Dieckmann, and D. Couvet 2004. Introduction. In R. Ferrière, U. Dieckmann, and D. Couvet, eds. Evolutionary Conservation Biology, pp. 1-14, 82-84. Cambridge University Press, Cambride, UK.
43. Foo, J., and F. Michor 2010. Evolution of resistance to anti-cancer therapy during general dosing schedules. Journal of Theoretical Biology 263:179-188.
44. Foo, J., and F. Michor 2014. Evolution of acquired resistance to anti-cancer therapy. Journal of Theoretical Biology 355:10-20.
45. Frankham, R., and J. Kingsolver 2004. Responses to environmental change: adaptation or extinction. In R. Ferrière, U. Dieckmann, and D. Couvet, eds. Evolutionary Conservation Biology, pp. 85-100. Cambridge University Press, Cambridge, UK.
46. Frankham, R., K. Lees, M. E. Montgomery, P. R. England, E. H. Lowe, and D. A. Briscoe 1999. Do population size bottlenecks reduce evolutionary potential? Animal Conservation 2:255-260.
47. Fry, J. D., and S. L. Heinsohn 2002. Environment dependence of mutational parameters for viability in Drosophila melanogaster. Genetics 161:1155-1167.
48. Gandon, S., and T. Day 2009. Evolutionary epidemiology and the dynamics of adaptation. Evolution 63:826-838.
49. Garant, D., S. E. Forde, and A. P. Hendry 2007. The multifarious effects of dispersal and gene flow on contemporary adaptation. Functional Ecology 21:434-443.
50. Gatenby, R. A., A. S. Silva, R. J. Gillies, and B. R. Frieden 2009. Adaptive therapy. Cancer Research 69:4894-4903.
51. Gillespie, D. T. 1977. Exact stochastic simulation of coupled chemical reactions. The Journal of Physical Chemistry 81:2340-2361.
52. Goldberg, D. E., R. F. Siliciano, and W. R. Jacobs, Jr 2012. Outwitting evolution: fighting drug-resistant TB, malaria, and HIV. Cell 148:1271-1283.
53. Goldie, J. H., and A. J. Coldman 1979. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treatment Reports 63:1727-1731.
54. Gomulkiewicz, R., and R. D. Holt 1995. When does evolution by natural selection prevent extinction? Evolution 49:201-207.
55. Gomulkiewicz, R., and D. Houle 2009. Demographic and genetic constraints on evolution. The American Naturalist 174:E218-E229.
56. Gomulkiewicz, R., and R. G. Shaw 2013. Evolutionary rescue beyond the models. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 368:20120093.
57. Gomulkiewicz, R., R. D. Holt, M. Barfield, and S. L. Nuismer 2010. Genetics, adaptation, and invasion in harsh environments. Evolutionary Applications 3:97-108.
58. Gonzalez, A., and G. Bell 2013. Evolutionary rescue and adaptation to abrupt environmental change depends upon the history of stress. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 368:20120079.
59. Gonzalez, A., O. Ronce, R. Ferrière, and M. E. Hochberg 2013. Evolutionary rescue: an emerging focus at the intersection between ecology and evolution. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 368:20120404.
60. Greulich, P., B. Waclaw, and R. J. Allen 2012. Mutational pathway determines whether drug gradients accelerate evolution of drug-resistant cells. Physical Review Letters 109:088101.
61. Haeno, H., and Y. Iwasa 2007. Probability of resistance evolution for exponentially growing virus in the host. Journal of Theoretical Biology 246:323-331.
62. Hamon, A., and B. Ycart 2012. Statistics for the Luria-Delbrück distribution. Electronic Journal of Statistics 6:1251-1272.
63. Hanahan, D., and R. A. Weinberg 2000. The hallmarks of cancer. Cell 100:57-70.
64. Handel, A., E. Margolis, and B. R. Levin 2009. Exploring the role of the immune response in preventing antibiotic resistance. Journal of Theoretical Biology 256:655-662.
65. Hedrick, P. W., and R. Fredrickson 2009. Genetic rescue guidelines with examples from Mexican wolves and Florida panthers. Conservation Genetics 11:615-626.
66. Hegreness, M. J., N. Shoresh, D. Damian, D. Hartl, and R. Kishony 2008. Accelerated evolution of resistance in multidrug environments. Proceedings of the National Academy of Sciences of the United States of America 105:13977-13981.
67. Hendry, A. P., M. T. Kinnison, M. Heino, T. Day, T. B. Smith, G. Fitt, C. T. Bergstrom et al. 2011. Evolutionary principles and their practical application. Evolutionary Applications 4:159-183.
68. Hermsen, R., J. B. Deris, and T. Hwa 2012. On the rapidity of antibiotic resistance evolution facilitated by a concentration gradient. Proceedings of the National Academy of Sciences of the United States of America 109:10775-10780.
69. Hokanson, J. A., B. W. Brown, J. R. Thompson, B. Drewinko, and R. Alexanian 1977. Tumor growth patterns in multiple myeloma. Cancer 39:1077-1084.
70. Holt, R. D., and R. Gomulkiewicz 2004. Conservation implications of niche conservatism and evolution in heterogeneous environments. In R. Ferrière, U. Dieckmann, and D. Couvet, eds. Evolutionary Conservation Biology, pp. 244-264. Cambridge University Press, Cambridge, UK.
71. Hooper, D. U., F. S. Chapin III, J. J. Ewel, A. Hector, P. Inchausti, S. Lavorel, J. H. Lawton et al. 2005. Effects of biodiversity on ecosystem functioning: a consensus of current knowledge. Ecological Monographs 75:3-35.
72. Huijben, S., A. S. Bell, D. G. Sim, D. Tomasello, N. Mideo, T. Day, and A. F. Read 2013. Aggressive chemotherapy and the selection of drug resistant pathogens. PLoS Pathogens 9:e1003578.
73. Iwasa, Y., M. A. Nowak, and F. Michor 2006. Evolution of resistance during clonal expansion. Genetics 172:2557-2566.
74. Johnson, V. A., V. Calvez, H. F. Günthard, R. Paredes, D. Pillay, R. Shafer, A. M. Wensing et al. 2011. 2011 Update of the drug resistance mutations in HIV-1. Topics in Antiviral Medicine 19:156-164.
75. Jumbe, N., A. Louie, R. Leary, W. Liu, M. R. Deziel, V. H. Tam, R. Bachhawat et al. 2003. Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy. Journal of Clinical Investigation 112:275-285.
76. Kepler, T. B., and A. S. Perelson 1998. Drug concentration heterogeneity facilitates the evolution of resistance. Proceedings of the National Academy of Sciences of the United States of America 95:11514-11519.
77. Kirkpatrick, M., and S. Peischl 2013. Evolutionary rescue by beneficial mutations in environments that change in space and time. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 368:20120082.
78. Komarova, N. L., and D. Wodarz 2005. Drug resistance in cancer: principles of emergence and prevention. Proceedings of the National Academy of Sciences of the United States of America 102:9714-9719.
79. Kopp, M., and S. Matuszewski 2014. Rapid evolution of quantitative traits: theoretical perspectives. Evolutionary Applications 7:169-191.
80. Lachapelle, J., and G. Bell 2012. Evolutionary rescue of sexual and asexual populations in a deteriorating environment. Evolution 66:3508-3518.
81. Lea, D. E., and C. A. Coulson 1949. The distribution of the numbers of mutants in bacterial populations. Genetics 49:264-285.
82. Levin, B. R., and D. E. Rozen 2006. Non-inherited antibiotic resistance. Nature Reviews Microbiology 4:556-562.
83. Lindsey, H. A., J. Gallie, S. Taylor, and B. Kerr 2013. Evolutionary rescue from extinction is contingent on a lower rate of environmental change. Nature 494:463-468.
84. Lipsitch, M., and B. R. Levin 1997. The population dynamics of antimicrobial chemotherapy. Antimicrobial Agents and Chemotherapy 41:363-373.
85. Lohbeck, K. T., U. Riebesell, and T. B. H. Reusch 2012. Adaptive evolution of a key phytoplankton species to ocean acidification. Nature Geoscience 5:346-351.
86. Luria, S. E., and M. Delbrück 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28:491-511.
87. Lynch, M. 2010. Evolution of the mutation rate. Trends in Genetics 26:345-352.
88. Lynch, M., and R. Lande 1993. Evolution and extinction in response to environmental change. In P. M. Kareiva, J. G. Kingsolver, and R. B. Huey, eds. Biotic Interactions and Global Change, pp. 234-250. Sinauer, Sunderland, MA.
89. Mansky, L. M., and H. M. Temin 1995. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. Journal of Virology 69:5087-5094.
90. Marcusson, L. L., N. Frimodt-Moller, and D. Hughes 2009. Interplay in the selection of fluoroquinolone resistance and bacterial fitness. PLoS Pathogens 5:e1000541.
91. Martin, G., and T. Lenormand 2006. The fitness effects of mutations across environments: a survey in light of fitness landscape models. Evolution 60:2413-2427.
92. Martin, G., R. Aguilee, J. Ramsayer, O. Kaltz, and O. Ronce 2013. The probability of evolutionary rescue: towards a quantitative comparison between theory and evolution experiments. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 368:20120088.
93. McLean, A. R., V. C. Emery, A. Webster, and P. D. Griffiths 1991. Population-dynamics of HIV within an individual after treatment with zidovudine. AIDS 5:485-489.
94. Merilä, J., and A. P. Hendry 2014. Climate change, adaptation, and phenotypic plasticity: the problem and the evidence. Evolutionary Applications 7:1-14.
95. Michel, J. B., P. J. Yeh, R. Chait, R. C. Moellering, Jr., and R. Kishony 2008. Drug interactions modulate the potential for evolution of resistance. Proceedings of the National Academy of Sciences of the United States of America 105:14918-14923.
96. Michor, F., T. P. Hughes, Y. Iwasa, S. Branford, N. P. Shah, C. L. Sawyers, and M. A. Nowak 2005. Dynamics of chronic myeloid leukaemia. Nature 435:1267-1270.
97. Millennium Ecosystem Assessment Board 2005. Ecosystems and Human Well-Being: Synthesis. Island Press, Washington, DC.
98. Nowak, M. A., and R. M. May 2000. Virus Dynamics: Mathematical Principles of Immunology and Virology. Oxford University Press, Oxford, UK.
99. Orr, H. A. 2005. The genetic theory of adaptation: a brief history. Nature Reviews Genetics 6:119-127.
100. Orr, H. A., and R. L. Unckless 2008. Population extinction and the genetics of adaptation. The American Naturalist 172:160-169.
101. Orr, H. A., and R. L. Unckless 2014. The population genetics of evolutionary rescue. PLoS Genetics 10:e1004551.
102. Osmond, M. M., and C. de Mazancourt 2013. How competition affects evolutionary rescue. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 368:20120085.
103. Otto, S. P., and M. C. Whitlock 1997. The probability of fixation in populations of changing size. Genetics 146:723-733.
104. Papp, B., R. A. Notebaart, and C. Pàl 2011. Systems-biology approaches for predicting genomic evolution. Nature Reviews Genetics 12:591-602.
105. Pease, C. M., R. Lande, and J. J. Bull 1989. A model of population growth, dispersal and evolution in a changing environment. Ecology 70:1657-1664.
106. Pena-Miller, R., D. Laehnemann, G. Jansen, A. Fuentes-Hernandez, P. Rosenstiel, H. Schulenburg, and R. Beardmore 2013. When the most potent combination of antibiotics selects for the greatest bacterial load: the smile-frown transition. PLoS Biology 11:e1001540.
107. Perron, G. G., A. Gonzalez, and A. Buckling 2007. Source-sink dynamics shape the evolution of antibiotic resistance and its pleiotropic fitness cost. Proceedings of the Royal Society of London. Series B: Biological Sciences 274:2351-2356.
108. Perron, G. G., A. Gonzalez, and A. Buckling 2008. The rate of environmental change drives adaptation to an antibiotic sink. Journal of Evolutionary Biology 21:1724-1731.
109. Ramsayer, J., O. Kaltz, and M. E. Hochberg 2013. Evolutionary rescue in populations of Pseudomonas fluorescens across an antibiotic gradient. Evolutionary Applications 6:608-616.
110. Read, A. F., T. Day, and S. Huijben 2011. The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapy. Proceedings of the National Academy of Sciences of the United States of America 108(Suppl 2):10871-10877.
111. Reed, T. E., D. E. Schindler, and R. S. Waples 2011. Interacting effects of phenotypic plasticity and evolution on population persistence in a changing climate. Conservation Biology 25:56-63.
112. Regoes, R. R., C. Wiuff, R. M. Zappala, K. N. Garner, F. Baquero, and B. R. Levin 2004. Pharmacodynamic functions: a multiparameter approach to the design of antibiotic treatment regimens. Antimicrobial Agents and Chemotherapy 48:3670-3676.
113. REX Consortium 2007. Structure of the scientific community modelling the evolution of resistance. PLoS ONE 2:e1275.
114. REX Consortium 2010. The skill and style to model the evolution of resistance to pesticides and drugs. Evolutionary Applications 3:375-390.
115. REX Consortium 2013. Heterogeneity of selection and the evolution of resistance. Trends in Ecology & Evolution 28:110-118.
116. Ribeiro, R. M., and S. Bonhoeffer 1999. A stochastic model for primary HIV infection: optimal timing of therapy. AIDS 13:351-357.
117. Ribeiro, R. M., and S. Bonhoeffer 2000. Production of resistant HIV mutants during antiretroviral therapy. Proceedings of the National Academy of Sciences of the United States of America 97:7681-7686.
118. Rong, L., H. Dahari, R. M. Ribeiro, and A. S. Perelson 2010. Rapid emergence of protease inhibitor resistance in hepatitis C virus. Science Translational Medicine 2:30ra32.
119. de Roode, J. C., R. Culleton, A. S. Bell, and A. F. Read 2004. Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections. Malaria Journal 3:33.
120. Samani, P., and G. Bell 2010. Adaptation of experimental yeast populations to stressful conditions in relation to population size. Journal of Evolutionary Biology 23:791-796.
121. Sanjuán, R., M. R. Nebot, N. Chirico, L. M. Mansky, and R. Belshaw 2010. Viral mutation rates. Journal of Virology 84:9733-9748.
122. Sarrazin, C., T. L. Kieffer, D. Bartels, B. Hanzelka, U. Muh, M. Welker, D. Wincheringer et al. 2007. Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir. Gastroenterology 132:1767-1777.
123. Schiffers, K., E. C. Bourne, S. Lavergne, W. Thuiller, and J. M. Travis 2013. Limited evolutionary rescue of locally adapted populations facing climate change. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 368:20120083.
124. Schindler, D. E., R. Hilborn, B. Chasco, C. P. Boatright, T. P. Quinn, L. A. Rogers, and M. S. Webster 2010. Population diversity and the portfolio effect in an exploited species. Nature 465:609-613.
125. Sorace, R., and N. L. Komarova 2012. Accumulation of neutral mutations in growing cell colonies with competition. Journal of Theoretical Biology 314:84-94.
126. Tomasetti, C. 2012. On the probability of random genetic mutations for various types of tumor growth. Bulletin of Mathematical Biology 74:1379-1395.
127. Toprak, E., A. Veres, J. B. Michel, R. Chait, D. L. Hartl, and R. Kishony 2012. Evolutionary paths to antibiotic resistance under dynamically sustained drug selection. Nature Genetics 44:101-105.
128. Torella, J. P., R. Chait, and R. Kishony 2010. Optimal drug synergy in antimicrobial treatments. PLoS Computational Biology 6:e1000796.
129. Uecker, H., and J. Hermisson 2011. On the fixation process of a beneficial mutation in a variable environment. Genetics 188:915-930.
130. Uecker, H., S. P. Otto, and J. Hermisson 2014. Evolutionary rescue in structured populations. The American Naturalist 183:E17-E35.
131. Vander Wal, E., D. Garant, M. Festa-Bianchet, and F. Pelletier 2013. Evolutionary rescue in vertebrates: evidence, applications and uncertainty. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences 368:20120090.
132. Visser, M. E. 2008. Keeping up with a warming world; assessing the rate of adaptation to climate change. Proceedings of the Royal Society of London, Series B: Biological Sciences 275:649-659.
133. Waxman, D., and S. Gavrilets 2005. 20 Questions on adaptive dynamics. Journal of Evolutionary Biology 18:1139-1154.
134. Weissman, D. B., and N. H. Barton 2012. Limits to the rate of adaptive substitution in sexual populations. PLoS Genetics 8:e1002740.
135. Willi, Y., J. Van Buskirk, and A. A. Hoffmann 2006. Limits to the adaptive potential of small populations. Annual Review of Ecology, Evolution, and Systematics 37:433-458.
136. World Health Organization 2014. Antimicrobial Resistance: Global Report on Surveillance. WHO Press, Geneva.
137. Wu, Y., C. A. Saddler, F. Valckenborgh, and M. M. Tanaka 2014. Dynamics of evolutionary rescue in changing environments and the emergence of antibiotic resistance. Journal of Theoretical Biology 340:222-231.
138. Zheng, Q. 1999. Progress of a half century in the study of the Luria-Delbrück distribution. Mathematical Biosciences 162:1-32.